Status:
COMPLETED
Prevalence of Hypertension in Type-2 Diabetes Mellitus
Lead Sponsor:
Kabul University of Medical Sciences
Conditions:
Prevalence of Elevated Blood Pressure in Type-2 Diabetics
Eligibility:
All Genders
Brief Summary
Cardiovascular disease is the most prevalent cause of morbidity and mortality in diabetic patients. Hypertension has been confirmed as a major risk factor for cardiovascular disease, which is frequent...
Detailed Description
Cardiovascular disease is the most prevalent cause of morbidity and mortality in diabetic patients. Hypertension has been confirmed as a major risk factor for cardiovascular disease, which is frequent...
Eligibility Criteria
Inclusion
- Clinically diagnosed diabetic patients
- Newly diagnosed Diabetics
- known case of diabetes
Exclusion
- The patients who were seriously ill
- Pregnant women
- Type-1 diabetic patients,
Key Trial Info
Start Date :
November 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 30 2020
Estimated Enrollment :
322 Patients enrolled
Trial Details
Trial ID
NCT05266885
Start Date
November 1 2019
End Date
January 30 2020
Last Update
March 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Habib Ahmad Esmat
Kabul, None Selected, Afghanistan, 35030